<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 370 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page369.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=370">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 370 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 370</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=370"><img src="../thumb/370.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Biologicals - 26                                                               2020-04 / 333
       other bld. constit., poss.infect.dis.due to transmiss.of infect. agents,   Booster dos.to ensure long term immunity: Admin. 6-18 mnths   at wkly.interv.to reach cumulat.mnthly dos): 2,5-5  ml/kg bm. Meas.
       benef.-risk ratio in pregn., 20% also: maint.adeq.hydrat.& monit.to   follow.init.dos.  trough lev in.order to adjust dos & dos.interv.
       guard against circulat. overload & overhydrat., if reqd.vol.of albumin   Contraindications: Fev., ac./chron.evolut.dis., neomyc.hypersens.,   Radiogen.mucosit: : Admin.IM. Init.10 ml (1 600 mg), follow.by 5 ml
       20 % exceeds 200 ml admin.addit.electr. sol. to maint.norm.fluid bal./  prev.hypersens.reacts., safety in pregn.not est.theref.not recomm.un-  (800 mg) aft.2 days & anoth. 5 ml (800 mg) aft.a furth.2 days. Treatm.
       cont.therapy with albumin 4 %, eosinophilia myalg.syndr.assoc.with   less clearly indicat.& risk vs.benef.eval., not known if excret.in hu-  can be rep.as often as necess.
       L-tryptophan intake.          man milk, not for intravasc.admin.or inj.to glut. area, anaphylax.hist.  Contraindications: Pts.known to have anti-IgA antibod., IMI not
       ATGAM, Pfizer, [P/S]          Side effects: Loc.reacts., mild fev., asthen., headache, myalg./  advoc.with bleed.disords./sev. thrombocytopen./disords.of haemo-
                                                                  stas., IV inj., safety in pregn.not est.
                                     arthralg., GI disturbs., urticar., rashes with/-out prurit., hypersens.
       Antithymocyte immunoglobulin (equine)  reacts.incl. anaphylax.  Side effects: Temp.elev., applic.site reacts., skin reacts., anaphylact.
       Indications: In combinat.with immunosuppress. ther. to manage   Special precautions: Do not freeze, immunisat. may be admin. dur.  manifest.with sensitis.subjects., chills, fev., headache, malaise., mod.
       allograft reject.in ren.transplant pt., mod.to sev.aplast.anaem.where   incubat.period in which case vaccinat.should not modify course of in-  back pain., syncope., dizzin., bronchosp., CV reacts., extracard. vasc.
       bone marrow transplantat.not suit.  fect., adeq. anti-HAV antibodies poss.not obt.aft.prim. immunisat. in   disords. incl.MI & stroke.
       (S4) INJ. T/30.4/717. 50 mg/ml.  pts.with impair.immune syst.theref. wait till end of suppress.treatm.  Special precautions: Incr.poss.of intravasc. inj. aft.repeat.IMI
       847089-010: 5x5 ml amp, R10 152,23  bef.vaccinat.or meas.antibody response, vaccinat.of pts.with chron.   which may cause shock-type syndr., monit.pts.dur.1  infus.& for 1   st
                                                                                        st
       Dosage: Prior to any infus.do skin & then intraderm. skin test.for   immunodefic.recomm.if underly.pathology allows even limit.antibody   hour theraft., monit. all pts.x20 mins.aft.admin., interf.with some se-
       poss.allerg.reacts. See product informat.for skin test proced., pre-  respons., does not prev. Hepatit.A/C/E or other liv.pathogens., lactat.,   rologic. tests, may impair effic.of live atten.virus vaccin. for 6 wks. - 3
       parat.& administrat.of solut.  adrenaline avail.in event of anaphylact.reacts., obt.prev.hypersens.  mnths, pre-exist.risk fact.for thromb.events., pts.on control.Na+ diet.
       Ren.allograft recipients: Delay.onset: 15 mg/kg dly x14 days then   hist.bef.admin., use diff.syringe & inject. site for other concom.vaccin.,
       every other day x14 days for a total of 21 dos.in 28 days. Admin.1st   tol.as well in hepatit.A seroposit.as seronegat., postpone vaccin. in   BOOSTRIX, GSK [P/S]
       dos.within 24 hrs.bef./aft.transplant.  ac.illn., less sev.manifestat.of prev. antibiot. hypersens.  Diphtheria toxoid 2,5 Lf, tetanus toxoid 5 Lf, Bordetella pertuss.an-
       Reject: On diagnos: 10-15 mg/kg dly x14 days. Addit.alt.day dos.  tigens: pertuss.toxoid 8 µg, filamentous haemagglutinin 8 µg, pert-
       may be given up to tot.of 21 dos.  BCG CULTURE SSI, Kahma Biotech [P/S]  actin 2,5 µg,/ 0,5 ml.
       Aplast.anaem: 10-20 mg/kg dly.x8-14 days. Addit.alt.day dos.may   Mycobacterium bovis (BCG)  Indications: Booster vaccin.against diphtheria, tetanus & pertus-
       be giv.up to tot.of 21 dos.   Indications: Immunoprophylax.in prim./recurr. grade Ta or T1 su-  sis from 4 yrs. onwards.
       Contraindications: Prior allerg.reacts.to equine gamma globul.,   perfic.bladd.Ca, in-situ immunother. treatm.of non-invas.bladd.Ca  (S2) INJ. 49/30.2/1042
       safety in pregn.& lactat.not est., usefuln.not est.in aplast.anaem.sec-  (S2) FREEZE-DRIED POWD, 32/30.1/0745  3000689-001:1x0,5 ml, Sngl.dos.pre-fill.syr., R277,15
       ond.to neoplast. dis./stor.dis./myelofibrosis/Fanconi’s syndr./ pts.with   702161-004: 30 mg, 4x4 ml vials, R1 985,02  Dosage: Shake well bef.use. Admin.deep IM. Sngl. 0,5 ml dos.
       known expos.to myelotox.agents or radiat./pts.with aplast.anaem   Dosage: Intraluminal urin.tract use only. Do not mix.in same ster.area   recomm.as sngl.dos.regimen. May be admin.to adolesc.& adults
       suit.candidat.for bone marrow transplantat., limit.exper.in childr.  as chemotherapeut.agents as iatrogen.transmiss.poss. Reconstit.4   with unknown vaccinat. status/ incompl.vaccinat.against diphtheria/
       Side effects: V.common: Thrombocytopen., leukopen., rash, ar-  vials in 50 ml sterile saline & instil slow.in empty bladd.via urethral   tetanus/ pertussis as part of immunisat. series against diphtheria/
       thralg., pyrex., chills. Common: infect., lymphadenopathy, headache,   catheter and retain.in bladd.x2 hrs. Void in norm.manner.  tetanus/ pertussis; In adults 2 addit.dos.of a diphtheria & tetanus con-
       dizzin., bradycard., tachycard., thrombophlebit., hypertens., hypotens.,   Recomm.dos: 120 mg or approx.1 x 10  CFU. Std sched.of 6 instil-  tain.vacc.are recomm.1 & 6 mnths. aft. 1st dos.to max.vacc.respon.
                                                     9
       dyspn., N&V, diarrh., upper abdom.pain, urticar., prurit., back/chest/  lat.with 1 wk.interv.betw.instillat. Treatm. sched.may be rep.once if   against diphtheria & tetanus. Repeat vaccinat.against diphtheria/
       infus.site pain, oed., arterioven.fistula thrombos. Uncommon: her-  insuffic./no respons. achiev. Maint.treatm.poss.in cert.high risk pts.  tetanus/pertussis should be perform. at interv.as per offic.recomm.
       pes simplex, ser.sickn., anaphylact. react., hyperglycaem., agitat.,   Contraindications: No handl./admin.to indiv. with congenit./acquir.  (S2)TETRA INJ, [P/S] 43/30.2/0526
       convuls., encephalit., paraesthes., ren.artery thrombos., iliac vein   immuno-defic incl.act.HIV/ indiv. current.treat.with immunosuppres.  Diphtheria toxoid 2,5 Lf, tetanus toxoid 5 Lf, Bordetella pertuss.anti-
       occlus., pleural effus., laryngosp., pulm.oed., stomatit., hiccups, night   drugs/ receiv. high dos.syst.corticoster.ther., act.TB, postpon. vacc.in   gens: pertuss.toxoid 8 µg, filamentous haemagglutinin 8 µg, pertactin
       sweats, allerg.dermatit., periorbit.oed., tox.epiderm.necrolys., protein-  UTI./unexplain.fev.until.urine culture negat./antibiot.or antisept.ther.  2,5 µg, inactiv. poliovirus.type 1 40 D-antigen units/type 2 8 D-antigen
       ur., asthen., malaise, abnorm.ren.funct.test/LFT, wound dehiscence.   ceas., postpone ther.x7-14 days aft, traumat.urothelium as treatm.  units/type 3 32 D-antigen units/ 0,5 ml.
       Unknown: Vir.hepatit., system. infect., local.infect., anaem., aplas.,   direct.aft.invas. proced.may result in system. BCG infect., avoid in   Indications: Booster vaccin.against diphtheria, tetanus, pertussis
       granulocytopen., haemolys., haemolyt.anaem., neutropen., pancyto-  pregn.& lactat.as no data avail.  & poliomyelit.from 4 yrs. onwards.
       pen., eosinophil., vasculit., confus. state, disorientat., dyskines., trem.,   Side effects: Incr.urin.freq., cystit., haematur., mild syst.influ.-like   716655-001: sngl.dos.pre-fill.syr., R326,06.
       syncope, CCF, DVT, GI haemorrh., apnoea, cough, epistax., abdom.   reacts., fev., malaise, allerg. reacts., arthral., myalg., rash, bladd.  Dosage: Shake well bef.use. Admin.deep IM. Sngl. 0,5 ml dos.
       pain, GI perforat, oral/ oropharyng. pain, flank/extremity pain, musc.  contract., tempor. urethral obstruct.  recomm.as sngl.dos.regimen.
       rigid., myalg., kidn. enlargem./rupture, ac.ren.fail., infus. site eryth./  Warnings: Special.anti-TB ther.& discont.ther.in the event of loc.BCG   Contraindications: Known hypersens.aft.prev. admin. of diphthe-
       swell., hyperhidros., pain.   infects./syst.reacts., investig. for prev.hypersens.& anaphylax.treatm.  ria/tetanus/pertussis vacc. (Boostrix) or diphtheria/tetanus/pertussis/
       Warnings and special precautions: Anaphylax. poss.at any time,   to be on hand, monit.for poss.syst. infect.in pres.of fev.  poliomyelit vacc. (Boostrix Tetra), prev. encephalopathy within 7 days
       discont.immed.& do not resume ther. in case of anaphylax., resp.distr./  Interactions: Do not admin.concom.drugs with known anti-my-  of pertussis cont. vacc., trans.thrombocytopaen./ neurolog.complic.
       hypotens may indic.anaphylact.react., pain in chest/flank/ back may   cobact.act.  foll.earlier tetanus &/diphtheria immunisat., IV admin. Boosterix
       indic.anaphylax./haemolys., pot.risk of cytokine release syndr., in pres.  Tetra also: formaldehyde/ neomycin/polimixin/polysorb.hypersens.
       of loc.posit.skin reacts. admin.only aft.risk evaluat.& with facilities &   BCG VACCINE SSI, Biovac Instit. [P/S]  Side effects: Childr.4-9 yrs: Very comm: Somnol., headache,
       doctor in attend.for poss.anaphylax., allerg. react. may occ.despite.  Mycobacterium bovis (BCG)  fatig, inj.site reacts.incl. pain/ redn./swell./haemorrh. Comm: Ano-
       neg.skin test., pos.skin test. will not predict later developm.of ser.  Indications: Act.TB immunisat.  rex., irritabil, fev., GI disords. Uncomm: Lymphadenopathy, diarrh.,
       sickn., monit. caref. for leucopen., thrombocytopen./concurr. infect.,   (S2) INJ. 29/30.2/0643. 0,75 mg/ml  N&V, abdom.pain, URTI, attent.disturbs., conjunctivit., rash, indurat.,
       incr.incid.of cytomegalovirus, sev.& unremitt. haemolys.may req.  872962-016: 20 dos./vials, 10 vials/box, R475,93  pain. Rare: Angioed., urticar., convuls., asthen. Very rare: Allerg.re-
       discont., poss. prophylact. platel.transfus.when treat.aplast. anaem.,   Dosage: Reconstit vacc.& admin.by slow. intraderm. inj.into upper   acts. incl. anaphylact.reacts., ascend.paralys./resp. paralys. Adults,
       poss.appear.of prev.mask.reacts.when immunosuppress. dos.reduc.,   skin layer 1/3 down upper (R) arm. Skin cleans.agents to dry bef.inj.  adolesc.& childr.from 10 yrs.: Very comm: Headache, inj.site re-
       admin.live-vir.vacc. 6 mnths.aft. Atgam ther., elderly  Childr.bel.1 yr: 0,05 ml. Adults & childr.over 1 yr: 0,1 ml.  acts.incl.pain/ redn./swell., naus., fatig., malaise. Comm: Dizzin., GI
       Interactions: Dilut.with dextr.may cause precipitat., highly acidic   Contraindications: Congenit./acquir. immunodefic., known HIV   disords., fev., inj.site haemorrh./mass/abscess. Uncomm: Prurit.,
       sols.poss.unstable over time.  infect., symptomat.AIDS, concurr. immunosuppress.treatm.incl.infts.  myalg., arthralg., chills, pain, URTI, pharyngit., lymphadenopathy,
                                     expos.to in utero/via breastfeed for as long as postnat. influence of   syncope, cough, diarrh., vomit., hyperhidros., rash, joint & muscu-
       AVASTIN, Roche                immune status poss. (eg matern. TNFalpha-antagon.treatm), where   loskelet. stiffn., influenza-like illn. Rare: Angioed., urticar., inj.site
       Bevacizumab                   immune status in quest., malign.condits eg.lymphoma/leukaem./   indurat., convuls., asthen. Very rare: Allerg.reacts.incl.anaphylact.
       Indications: Metastat.colon or rectum adenocarcin. in combinat.  Hodgkins dis/other reticulo-endothel.syst.tumours.  reacts., ascend.paralys./resp.paralys. Boosterix Tetra also: Childr.
       with fluoropyrimidine-based chemother., 1  line loc.recurr./metast.   Side effects: Loc.reacts., trans.reg.lymph node enlargem. Less.freq:   Uncommon: Sleep disord., apathy, dry throat. Adults: Oral herpes,
                         st
       breast adenocarcin. in combin.with paclitaxel, 1  line unresect.  Axill.lymph node enlargem., suppurat.lymphadenit., osteomyelit.,   decr. appet., paraesthes., somnol., asthma.
                            st
       advanc./metastat./recurr.lung adenocarcin. in addit.to platinum-  inj.site abscess./ ulcerat./discharge, anaphylact.react., allerg.react.,   Warnings and special precautions: Boosterix Tetra not intend.
       based chemother., 1  line advanc. &/ metast. ren.cell Ca with in-  headache, lupus type react., keloid format., osteitis, disseminat.BCG   for prim.immunisat., admin.in accord. with offic.recomm., postpone in
                st
       terferon alfa-2a.             dis.partic.in immune-suppress., fev.  ac.sev. febr. illn., appropr.med.treatm./supervis.to be avail., medic.hist.
       (S4) INFUS, A39/26/0314, 0315. 25 mg/ml  Warnings and special precautions: Seek special. advice bef.vac-  review esp.regard.prev.vaccin. bef. admin., cons.benef./risk in case of
       706042-002: 100 mg, 1x4 ml vial, R4 478,80  cinat.if immunosuppress. agents prev.admin., postpon.vacc.in ac.illn./  temp. &gt;40°C with.48 hrs.of vacc.not due to identify. cause/ collapse
       706041-002: 400 mg, 1x16 ml vial, R17 915,19  high fev.& ser.skin dis., observ.for 20 mins.aft.admin.& have emerg.  or shock-like state with.48 hrs.of vaccinat./ persist./unconsoll.cry.last.
       For further details refer to prof.info.  anaphylax.treatm.avail., poss.sev.loc. react.if admin.to tuberculin-  &gt;3 hrs. occur. with.48 hrs.of vaccin./convuls.with/ without fev. occur.
       AVAXIM, Sanofi-Aventis [P/S]  posit.pts., deep admin. incr.risk of discharg.ulc./abscess format.&   with.3 days of vaccin.all in relat. to receipt of pertussis-contain.vacc.
                                     reg. lymphadenit., safety in pregn.not est.
       Inactivat.hepatit.A vacc.(GBM strain)  Interactions: Admin.other live vac.at same time or not less than   in infancy, thrombocytopaen./ bleed.disord., pref.defer pertuss. immu-
                                                                  nisat.in childr.with progress. neurolog. disords.incl.infantile spasms/
       Indications: Activ.immunisat.against Hepatit.A infect..in adolesc.  4 wk.aft.vaccinat.
       from 16 yrs.& adults at incr.risk.                         uncontr. epilep. /progress.encephalopathy unt.condit. correct./ sta-
                                                                  ble, indiv.decis.to give pertussis vacc. consid. of risks vs.benef, eff.
       (S4) 160 INJ. 30/30.1/0244    BERIGLOBIN P, (Actor Pharma) Mirren [P/S]  on fertility/ embryo-foet. developm.not est., syncopy follow./bef.
       848905-008: 160 antigen units/0,5 ml, 1x0,5 ml prefil.syringe, R281,60  Human immunoglob.  vaccinat. as psychogen.respon.to needle inj., avoid Boosterix.Tetra
       Dosage: Admin IMI in deltoid reg. SC admin.may be consid.in   Indications: Hepatit.A.prophylax.in travellers present.&lt;2wks bef.  dur.pregn., Boostrix may be consid. dur.3  trimest.of pregn.& should
                                                                                   rd
       thrombocytopen/pts.at risk of haemorrh. Do not mix with other   poss.expos.pref.in combinat. with vaccinat./persons expos.&lt;2   be used as per nation. immunisat.guidelin.for pregn.women, lactat.,
       vacc.in same syringe          wks.prev., ther.of radiogen.mucosit., replac.ther.in adults & childr.  boost.respons.only elic.if prev.indiv. vaccin./ by natur.infect., may be
       Adults & childr.over 16 yrs: Recomm.dos: 0,5 ml for each inject.  in prim.immunodefic.syndr.incl.congenit. agammaglobulinaem.&   used in tetanus prone injury if prim.vaccin.series receiv. prev. with
       Prim.immunisat: 1 sngl.dos.   hypogammaglobulinaem./ comm. var.immunodefic./sev.combin.  concom. tetan.immunoglob.in accord.with offic. recomm., protect.
       Booster dos.to ensure long term immunity: Admin.6 –36   immunodefic. / IgG subclass.defic.with recurr.infects., replacem.   durat.against pertussis foll. vaccinat. not est., concom.admin.with
       mnths later.                  ther.in myeloma/chron.lymphocyt.leukaem.with sev. second.  other inactivat. vaccin.not stud, prod.to be admin.at diff. sites should
       (S4) 80 INJ. 35/30.1/0401     hypogammaglobulinaem. & recurr. infects.  concom.other vaccin./immunoglobul. be neccess., protect.immune
       Indications: Activ.immunisat.against Hepatit.A infect..in childr.12   (S4) INJ. T/30.2/608,609. 160 mg/ml  respon.may not be elicit. in all vaccinees, poss.inadeq.respons.with
       mnths - 15 yrs at risk of either contaminat./spread.infect.or of a life   707783-003: 1x2 ml, R596,97  immunosuppress. ther./immunodefic.pts., do not mix.with other meds.
       threat.dis.if infect.         707791-006: 1x5 ml, R1 492,51
       700513-001: 80 antigen units/0,5 ml, 1x0,5 ml prefil.syringe, R227,15  Dosage:   BOTOX, Allergan [P/S]
       Dosage: Admin IMI in deltoid reg./quadricepts in childr.accord.to age.   Hepatit.A prophylax: Admin.IM. Post expos.to Hepatit.A:   Sterile vacuum dried form of purif.botulinum toxin type A
       SC admin.may be consid.in thrombocytopen/pts.at risk of haemorrh.   0,02 ml/kg bm within 2 wks. Travellers to endem.areas for stays.&lt;   Indications: Neurolog.disords: Foc.spastic. assoc. with dynam.
       Do not mix with other vacc.in same syringe  3mnths: 0,02 ml/kg bm  equinus foot deform.due to spasticity in paed.cerebr.palsy pts.2 yrs.&
       Recomm.dos: 0,5 ml for each inj.  Replacem.ther: Indiv.dos. Admin.SC. Load.dose: 1,3-3,1 ml/kg   old., foc.spastic.of wrist & hand in adult post-stroke pts., select.cas. of
       Prim.immunisat: Childr.12 mnths – 15 yrs: 1 sngl.dos.  bm.div.over sev.day with max.dly.dos 0,1-0,15 g/kg. Maint. (ideally   strabism. & blepharosp, assoc. with dyston.incl.benign essent.blepha-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page369.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page365.html">365</a>&nbsp;&nbsp;&nbsp;<a href="page366.html">366</a>&nbsp;&nbsp;&nbsp;<a href="page367.html">367</a>&nbsp;&nbsp;&nbsp;<a href="page368.html">368</a>&nbsp;&nbsp;&nbsp;<a href="page369.html">369</a>&nbsp;&nbsp;&nbsp;<a href="page370.html">370</a>&nbsp;&nbsp;&nbsp;<a href="page371.html">371</a>&nbsp;&nbsp;&nbsp;<a href="page372.html">372</a>&nbsp;&nbsp;&nbsp;<a href="page373.html">373</a>&nbsp;&nbsp;&nbsp;<a href="page374.html">374</a>&nbsp;&nbsp;&nbsp;<a href="page375.html">375</a>
             </td>
             <td width="35%"><a href="page371.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page371.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
